Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database

被引:0
作者
Michael S. Broder
Beilei Cai
Eunice Chang
Maureen P. Neary
机构
[1] Partnership for Health Analytic Research,
[2] Novartis Pharmaceuticals Corporation,undefined
来源
BMC Pulmonary Medicine | / 18卷
关键词
Lung neuroendocrine tumors; Epidemiology; Prevalence; Incidence; Insurance claims;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 96 条
[1]  
Korse CM(2013)Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry Eur J Cancer 49 1975-1983
[2]  
Taal BG(2008)Gastroenteropancreatic neuroendocrine tumours Lancet Oncol 9 61-72
[3]  
van Velthuysen M-LF(2008)Neuroendocrine tumors of the diffuse neuroendocrine system Curr Opin Oncol 20 1-12
[4]  
Visser O(2008)One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 3063-3072
[5]  
Modlin IM(2016)Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis Ann Oncol 27 68-81
[6]  
Oberg K(2013)The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study PLoS One 8 e62487-R163
[7]  
Chung DC(2014)On behalf of the knowledge NETwork. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature Endocr Relat Cancer 21 R153-64
[8]  
Jensen RT(2015)Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis J Gastroenterol 50 58-597
[9]  
de Herder WW(2015)Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes Cancer 121 589-766
[10]  
Thakker RV(2017)Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States JAMA Oncol 3 1335-3682